ERIS LIFESCIENCES
Back to Cashflow Statement
|
ERIS LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹538 Cr | ₹1,065 Cr | ₹486 Cr | ₹292 Cr | ₹378 Cr |
What is the latest Cash Flow from Operating Activities ratio of ERIS LIFESCIENCES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹538 Cr |
| Mar2025 | ₹1,065 Cr |
| Mar2024 | ₹486 Cr |
| Mar2023 | ₹292 Cr |
| Mar2022 | ₹378 Cr |
How is Cash Flow from Operating Activities of ERIS LIFESCIENCES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹538 Cr | -49.48 | |
| Mar2025 | ₹1,065 Cr | 119.13 | |
| Mar2024 | ₹486 Cr | 66.59 | |
| Mar2023 | ₹292 Cr | -22.87 | |
| Mar2022 | ₹378 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹17,088.5 Cr | 5.9% | 7.4% | -22.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 5.9% |
7.4% |
-22.6% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses